Vera Therapeutics, Inc.

NasdaqGM:VERA Stock Report

Market Cap: US$2.4b

Vera Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:VERA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
10 Apr 24SellUS$228,560Joseph YoungIndividual5,714US$40.00
03 Apr 24SellUS$735,205Sean GrantIndividual18,649US$40.06
25 Mar 24SellUS$34,099,583Sofinnova Investment, Inc.Company834,459US$46.18
30 Jan 24BuyUS$4,999,990Sofinnova Investment, Inc.Company161,290US$31.00
10 Jan 24SellUS$18,900,000Commodore Capital LPCompany1,050,000US$18.00
31 Jul 23SellUS$9,450,261Abingworth LLPCompany544,073US$18.53
30 Jun 23SellUS$9,567,747Abingworth LLPCompany543,394US$18.31
23 Jun 23BuyUS$83,000Sean GrantIndividual5,000US$16.60
20 Jun 23BuyUS$6,799,004Commodore Capital LPCompany448,217US$15.17

Insider Trading Volume

Insider Buying: VERA insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of VERA?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders311,7530.573%
Private Companies1,921,8033.53%
Hedge Funds4,400,0008.08%
General Public6,352,64811.7%
VC/PE Firms7,938,19914.6%
Institutions33,527,62661.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 23%.


Top Shareholders

Top 25 shareholders own 81.01% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.45%
Longitude Capital Management Co., LLC
5,144,212US$231.2m0%46.92%
8.08%
Commodore Capital LP
4,400,000US$197.7m-19.3%12.13%
6.7%
Kynam Capital Management, LP
3,650,339US$164.0m23.5%11.55%
5.13%
Sofinnova Investment, Inc.
2,793,987US$125.6m-19.4%9.08%
5.1%
FMR LLC
2,774,351US$124.7m-49.1%0.01%
5.06%
BlackRock, Inc.
2,754,894US$123.8m16.8%no data
4.6%
Woodline Partners LP
2,507,140US$112.7m-2.16%1.19%
4.01%
State Street Global Advisors, Inc.
2,181,058US$98.0m26.2%no data
3.52%
Eversept Partners, L.P.
1,914,830US$86.1m29.5%6.73%
3.51%
E. Merck KG
1,913,501US$86.0m0%no data
3%
The Vanguard Group, Inc.
1,633,608US$73.4m3.76%no data
2.79%
OrbiMed Advisors LLC
1,518,115US$68.2m0%0.88%
2.47%
Kleiner Perkins Caufield & Byers
1,343,152US$60.4m-31.1%10.75%
2.44%
Pictet Asset Management Limited
1,328,540US$59.7m8.35%0.04%
2.04%
Schroder Investment Management Limited
1,110,960US$49.9m0%0.03%
1.99%
T. Rowe Price Group, Inc.
1,081,834US$48.6m55,000%no data
1.83%
Point72 Asset Management, L.P.
997,184US$44.8m0%0.09%
1.82%
Morgan Stanley, Investment Banking and Brokerage Investments
992,250US$44.6m9%0.01%
1.44%
Geode Capital Management, LLC
782,716US$35.2m5.98%no data
1.33%
Polar Capital Holdings Plc
725,000US$32.6m0%0.13%
1.16%
Deutsche Asset & Wealth Management
633,685US$28.5m3,850%0.01%
1.13%
Altium Capital Management LP
615,000US$27.6m84.3%14.73%
1.12%
Goldman Sachs Group, Investment Banking and Securities Investments
610,349US$27.4m58.3%0.01%
0.7%
AXA Investment Managers S.A.
382,691US$17.2m41.2%0.03%
0.59%
Northern Trust Global Investments
321,835US$14.5m8.91%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.